# Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

> **NCT01035749** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 310 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK Biologicals' Influenza investigational vaccine GSK2340274A
- **BIOLOGICAL:** GSK Biologicals' Influenza investigational vaccine GSK2340273A
- **BIOLOGICAL:** Placebo (saline)

## Key facts

- **NCT ID:** NCT01035749
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-01
- **Primary completion:** 2010-09-27
- **Final completion:** 2011-05-10
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01035749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01035749, "Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01035749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*